Navigation Links
Catalent Signs Commercial Manufacturing Agreement with US WorldMeds for Lofexidine
Date:9/5/2017

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has entered into an exclusive agreement with US WorldMeds, LLC for the commercial manufacture of lofexidine, an investigational drug under development to mitigate symptoms associated with opioid withdrawal and facilitate completion of opioid discontinuation treatment.

US WorldMeds has the rights to commercialize lofexidine in the U.S., which is currently approved as Britlofex™ in the United Kingdom. Catalent and US WorldMeds have worked together to successfully tech transfer the manufacturing from a facility overseas to Catalent’s Winchester, Kentucky, facility, where they have produced registration batches to support US WorldMeds’ New Drug Application to the Food and Drug Administration (FDA) and the anticipated commercial launch.

Lofexidine received Fast Track designation by the FDA, a process designed to expedite the review of drugs that treat serious conditions and address an unmet medical need. If approved, lofexidine would be the first non-narcotic and non-addictive medication in the United States for treatment of symptoms associated with opioid withdrawal.

“Symptoms of opioid withdrawal can be a significant barrier in seeking help and breaking the cycle of dependence and addiction. We are excited to join forces with US WorldMeds to bring a potential new treatment option to a major health issue spanning the nation.”

Catalent’s Winchester, facility has more than 20 years’ experience in product development, technology transfer and commercial manufacturing. The site has produced over three billion tablets and capsules annually and launched more than 100 new products into the market since its inception.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated more than $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2017/09/prweb14660080.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Catalent Provides Commercial Manufacturing of Lexicon Pharmaceuticals' Orphan Drug XERMELO™ Following FDA Approval
2. Catalent to Launch Innovative Fish Oil Supplement Product at Vitafoods Europe
3. Challenges and Strategies to Automate Potency Assays to be Discussed by Catalent Expert at Upcoming CASSS Bioassays Symposium
4. Catalent Expands Kansas City Clinical Storage and Secondary Packaging Capabilities to Meet Growing Demand for Cold Chain Services
5. Catalent Wins Prestigious Clinical Supply Chain Excellence Award at BioPharma Asia Convention
6. Challenges and Innovation in Clinical Trial Supply to be Presented by Catalent Experts at Upcoming Conferences
7. Catalent to Host Workshop with Leading Biologics Experts on Advanced Protein Development and Delivery at Upcoming Drug Delivery Partnerships Conference
8. Innovative Strategies for the Development of Lipid-based Oral Medicines to be Presented by Catalent and Gattefossé at Forthcoming Workshop
9. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
10. Catalent to Develop Softgel Capsules for JOT’s Leading Orphan Disease Candidates
11. Catalent Biologics Collaborates with PATH Malaria Vaccine Initiative to Create Antibodies for Malaria Vaccine Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2020)... ... May 27, 2020 , ... The podiatrists and foot doctors ... Michigan, Fowlerville Michigan , and Ann Arbor Michigan. Dr. Tomasz Biernacki ... within the clinic and at the hospital. We have been seeing patients in the ...
(Date:5/26/2020)... ... May 26, 2020 , ... New research ... the brain causing post infectious encephalitis. The work was conducted to determine ... (Pediatric Acute-onset Neuropsychiatric Syndrome) could adversely attack the central nervous system and ...
(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, ... advocate Joan Price have just received the 2020 AASECT Audio Visual Award for jessica ... was the first of its kind to feature non-actors in its demonstrations and narratives ...
(Date:5/21/2020)... FALLS CHURCH, Va. (PRWEB) , ... ... ... CRC Trainer:, An Interactive Companion to the CRC’s Guide to Coordinating Clinical ... the spectrum of clinical research management, The CRC Trainer: An Interactive Companion ...
(Date:5/21/2020)... ... May 21, 2020 , ... Fujirebio Diagnostics, Inc., ... biomarker assays, announced today that Cigna has added ROMA® (Risk of Ovarian Malignancy ... service company dedicated to improving the health, well-being, and peace of mind of ...
Breaking Medicine News(10 mins):
(Date:5/26/2020)... ... 26, 2020 , ... SignatureCare Emergency Center, your friendly neighborhood 24-hour Texas emergency ... new ER is set to open early June, 2020, and will be located on ... 130, Bldg.4, Pflugerville, TX. , According to Dr. Aaron Braun , a board-certified ...
(Date:5/26/2020)... ... 2020 , ... Rize Health, an innovative clinical ... them with revolutionary clinical trial solutions. , Through this strategic partnership, Rize Health ... enables onboarding, scheduling, and remote data capture - right from your fingertips. The ...
(Date:5/25/2020)... , ... May 25, 2020 , ... AltMed Florida ... continues its statewide expansion with a three-day, Memorial Day Opening, starting Monday May 25 ... Springs. , During the opening, staggered over three-days for crowd mitigation, all licensed Florida ...
Breaking Medicine Technology: